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Involuntary inhalation of tobacco smoke has been shown to aggravate the allergic response. Antibodies
to fungal antigens such as Aspergillus fumigatus (Af) cause an allergic lung disease in humans. This
study was carried out to determine the effect of environmental tobacco smoke (ETS) on a murine model
of allergic bronchopulmonary aspergillosis (ABPA). BALB/c mice were exposed to aged and diluted
sidestream cigarette smoke to simulate ‘second-hand smoke’. The concentration was consistent with
that achieved in enclosed public areas or households where multiple people smoke. During exposure,
mice were sensitized to Af antigen intranasally. Mice that were sensitized to Af antigen and exposed to
ETS developed significantly greater airway hyperreactivity than did mice similarly sensitized to Af but
housed in ambient air. The effective concentration of aerosolized acetylcholine needed to double
pulmonary flow resistance was significantly lower in Af þ ETS mice compared to the Af þ AIR mice.
Immunological data that supports this exacerbation of airway hyperresponsiveness being mediated by
an enhanced type 1 hypersensitivity response include: eosinophilia in peripheral blood and lung
sections. All Af sensitized mice produced elevated levels of IL4, IL5 and IL10 but no IFN-g indicating
a polarized Th2 response. Thus, ETS can cause exacerbation of asthma in ABPA as demonstrated by
functional airway hyperresponsiveness and elevated levels of blood eosinophilia.
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INTRODUCTION
The inhalation of environmental tobacco smoke (ETS)
also known as “second-hand smoke” has been shown to
have adverse effects on the health of nonsmokers.
Epidemiological studies have concluded that exposure to
ETS is responsible for some forms of cancer, respiratory
disease and may also exacerbate the allergic response
(Martinez et al., 1988; Stone, 1992; El-Nawawy et al.,
1996; Gilliland et al., 2001). Studies on human subjects
are rarely able to focus on ETS alone due to concurrent
exposure to other environmental pollutants (such as
ozone, diesel exhaust) which may also modulate the
immune response. For this reason, we have previously
studied the effects of ovalbumin (OVA) -sensitized mice
in aged and diluted side stream cigarette smoke (Seymour
et al. 1997; Seymour et al., 2002) produced by a smoke
generation system that simulates “second-hand smoke”
(Teague et al., 1994). In this model, we found that OVA-
sensitized BALB/c mice exposed to ETS resulted in
the upregulation of the allergic response. There were
increases in the cellularity of the bronchoalveolar lavage
(BAL) and in T helper cell type 2 (Th2) cytokines of the
lungs, particularly IL4 and IL10. Serum and blood
analysis revealed increased levels of circulating IgE, IgG1
and eosinophils from ETS exposed OVA-sensitized mice.
The effects of ETS were more profound on females
when compared to male mice (Seymour et al., 2002).
We (Seymour et al., 1998) and others (McMenamin et al.,
1994) have shown that repeated exposure of naive adult
mice to aerosolized OVA resulted in IgE unresponsive-
ness. However Rumold et al. (2001) have demonstrated
that exposure of naı¨ve adult mice to aerosolized OVA
along with ETS resulted in elevated levels of serum IgE
and eosinophils in the BAL. These observations prompted
an interest in further investigating the effects of ETS on
exposure to a clinically relevant and more complex
antigen. Thus, we chose to examine the effects of ETS on
an established animal model of allergic bronchopulmon-
ary aspergillosis (ABPA) (Kurup et al., 1992).
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ABPA is a complex hypersensitivity lung disease
caused by the inhalation of Aspergillus fumigatus (Af)
antigens (reviewed in Grunig et al. (1998a)), with
components of both immediate and delayed type
hypersensitivity. This opportunistic fungal pathogen is
generally found in homes particularly in the farming
population (Kauffman et al., 1995). ABPA is prevalent
among patients with cystic fibrosis (Laufer et al., 1984)
and is characterized by elevated levels of serum IgE and
eosinophils indicating a Th2 response (Kauffman et al.,
1995). Indeed, in a murine model of ABPA, Th2
cytokines, particularly IL4 and IL5, were detected in
cell cultures from the lungs (Kurup et al., 1992; Kurup
et al., 1994a) and BAL (Grunig et al., 1997) of Af
sensitized mice and administration of antibodies to IL4
and IL5 abrogated the IgE and eosinophilia in these
animals (Kurup et al., 1994b).
Enhanced allergic sensitization to Af and other fungal
antigens, as demonstrated by skin tests, has been
reported in atopic children (Ronchetti et al., 1992).
However, investigators have also reported that the
incidence of ABPA is less prevalent in smokers than in
nonsmokers (reviewed in Holt (1987)). Studies have
revealed that the allergic response from Af antigen is an
event involving not only Th2 but also the Th1 cytokine,
IFN-g that is regulated by endogenous IL10 (Grunig
et al., 1997). Thus ABPA has a more complex
pathogenesis than simple type 1 hypersensitivity as
demonstrated in the OVA model of allergy (Seymour
et al., 1997). Although the mechanism through which
cigarette smoke modifies risk factors to ABPA is
unknown, we believe it is immunologic in nature.
In order to understand how cigarette smoke may
influence this disease, we exposed BALB/c mice to
ETS, while concurrently delivering via the intranasal
(i.n.) route, Af or phosphate buffered saline (PBS). We
hypothesized that development of airway hyperrespon-
siveness, eosinophilia and production of Th2 cytokines
would be enhanced by exposure to ETS.
METHODS
Animals
Specific pathogen-free BALB/c mice from Charles Rivers
(Hollister, CA) were 8–9 weeks old at the start of each
experiment. Female mice were used to avoid injury and
subsequent inflammation that often results from male
fighting.
Preparation and Administration of the Af Antigen
The Af antigen was a mixture of mycelial extract and
culture filtrate. Af was grown and antigen prepared as
previously described (Kurup et al., 1992). Briefly, Af was
grown in synthetic broth for 2–3 weeks. The culture
filtrate was dialyzed against deionized water and freeze-
dried. A French press (S.L.M. Instruments, Urbana, IL)
was used for extraction of the mycelium extract. This was
done by homogenizing the mycelium at 10,000 psi for
extraction of the antigen. These antigens were evaluated
for their protein content and their level of reactivity with
patients’ serum. Two hundred micrograms of Af was
evaluated to have 50mg of protein. These exposures were
done by using a pipette to instill the Af i.n. into mice
anesthetized lightly with ether.
Experimental Protocol
BALB/c mice were exposed to ETS or ambient air from
day 0 through day 43 (Fig. 1). They were sensitized by
instillation of 50ml of soluble Af antigen into their nostrils
on days 14, 17, 21 and 24. In three separate experiments
different doses of Af were studied: 200, 100, 50 and 25mg.
Control mice were given 50ml of PBS i.n. and exposed
either to ETS or ambient air from days 0 through 43.
The ETS concentration was at a high ambient level, but
similar to those observed in restaurants, bars and the
homes of smokers. During ETS/ambient air exposures
animals were bled from their tail veins for IgE antibodies
FIGURE 1 Antigen sensitization and ETS/AIR exposure protocols.
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and eosinophil determination. Cytokine production
was carried out by in vitro stimulation of lung cells on
day 4 after the final Af or PBS challenges.
Research Cigarettes
The cigarette used in this study was the IR4F that is a
filtered cigarette used by research laboratories. They
were obtained from the Tobacco and Health Research
Institute (University of Kentucky, Lexington, KY). Once
purchased, they were stored at 48C until used in an
experiment. Two days before use, they were placed at 238C
in a chamber containing water and glycerol (this mixture
was at a ratio of 0.76:0.26) in order to achieve a relative
humidity of 60%.
The Smoke Generation System
The smoke generation system was designed by Teague
and colleagues (Teague et al., 1994). Whenever the
animals were not receiving ETS, a source of filtered air
was delivered to the mice so that mice exposed to ETS can
be housed in these chambers for the duration of the
experiment.
ETS Exposure
Mice were exposed to ETS for 6 h per day from Monday
through Friday. At the end of the daily exposure, the
smoke generator was turned off but the animals remained
in the exposure chambers. Each exposure chamber had a
measurement of 69 £ 69 £ 61 cm3 with a complete
change of air every 3 min. Up to 48 mice in 12 cages were
housed in a single chamber.
The total suspended particulates (TSP) from the
experiment in which mice were exposed to 200mg Af
per exposure revealed a TSP concentration of 1:00 ^
0:15 mg=m3: The nicotine and carbon monoxide concen-
trations were 159 ^ 55mg=m3 and 6:6 ^ 0:9 ppm;
respectively. The relative humidity was 41:0 ^ 9:0%
while the temperature was 23:0 ^ 1:08C: The TSP from
the experiment in which mice were challenged with low
doses of Af (25, 50 and 100mg Af per exposure), was
1:00 ^ 0:05 mg=m3: The nicotine and carbon monoxide
concentrations were 237 ^ 109mg=m3 and 6:8 ^
0:9 ppm; respectively. The relative humidity was 48:0 ^
10% while the temperature was 20 ^ 1:08C: Measure-
ments of TSP and nicotine after the system was turned off
revealed a rapid decline to nondetectable levels
ð, 15mg=m3Þ during the nonsmoking period.
Airway Responsiveness Measurements
Airway responsiveness to increasing concentrations of
acetylcholine aerosols was determined in 110 mice.
The mice studied were divided into eight experimental
groups, that included: ambient air exposed with nasal
instillation of PBS ðn ¼ 16Þ; ambient air exposed with
nasal instillation of 25mg Af/exposure ðn ¼ 12Þ; ambient
air exposed with nasal instillation of 50mg Af/exposure
ðn ¼ 11Þ ambient air exposed with nasal instillation of
200mg Af/exposure ðn ¼ 11Þ; ETS exposed with nasal
instillation of PBS ðn ¼ 23Þ; ETS exposed with nasal
instillation of 25mg Af per exposure ðn ¼ 12Þ; ETS
exposed with nasal instillation of 50mg Af per exposure
ðn ¼ 13Þ; ETS exposed with nasal instillation of 200mg
Af per exposure ðn ¼ 12Þ:
On the day of pulmonary function testing the mice were
weighed, anaesthetized with an i.p. injection of 2.5%
a-chloralose and 25% urethane (0.006 ml/gr body weight)
and their trachea were cannulated. Next, the mice were
placed in a whole body plethysmogaph and their tracheal
cannula attached to a constant volume positive pressure
ventilator (model 683, Harvard Inc.) set at a tidal volume of
0.20 ml and a frequency of 120 breaths/min. The mice were
then paralyzed with succinyl chlorine (0.05 ml of 20 mg/ml,
i.p.) and the plethysmograph was closed. Air flow was
measured using a pneumotachograph (model 8300, Hans
Rudolph Inc.) mounted into the lid of the plethysmograph.
Airway pressure was measured using a differential pressure
transducer (Statham Laboratories, Inc.) with one side
attached near the tracheal cannula port of the ventilator and
the other side attached to a port on the side of the
plethysmograph. The air flow and airway pressure signals
were amplified and then recorded and analyzed using a
digital data acquisition system (PO-NE-MAH, Inc.).
Pulmonary flow resistance (RL) was calculated according
to the method of Amdur and Mead (Amdur and Mead, 1958)
with air flow and airway pressure being measured at an
isovolume of 70% of tidal volume. Doubling concentrations
of acetylcholine solutions, starting at 0.125 mg/ml were
aerosolized using a jet nebulizer (Miniheart, Vortran, Inc.)
and delivered to the mice by passing the aerosol stream past
the inlet of the ventilator. Increasing concentrations of
acetylcholine were used until RL doubled or a concentration
of 64 mg/ml acetylcholine was reached. RL was corrected for
the known resistance of each tracheal cannula. The effective
concentration needed to double RL (EC200RL) was
calculated by interpolation of the log/log plot of the
acetylcholine dose response curve.
Quantification of Eosinophils in the Peripheral Blood
Eosinophils were quantified by dilution of heparinized
blood in Discombe’s fluid as previously described (Colley,
1972). This cell suspension was placed on a hemo-
cytometer and eosinophils counted with a light
microscope.
Examination of Eosinophils in Lung Tissue Sections
To determine the presence of eosinophils in lung tissues,
5mm thick paraffin sections were stained with hematoxylin
and eosin and with a special stain for eosinophils and
mast cells (combined Eosinophil/Mast cell stain [CEM],
American Master Tech Scientific, Lodi, CA).
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In-vitro Stimulation of Homogenized Lung Cells
Mice were euthanized and their lungs removed aseptically,
cut into small pieces and forced against a sterile No. 100
steel mesh (Tylinter Inc., Mentor, OH) with the piston of a
10 ml plastic syringe. The cells were washed three times in
Hank’s solution (GIBCOBRL, Grand Island, NY) then
suspended in culture medium at 5 £ 106=ml: The culture
medium consisted of RPMI 1640 (J.H.R. Bioscience,
Lenexa, KS.) with 10% heat-inactivated fetal calf serum
(FCS) (Sigma, St Louis, MO.), 0.05 mM 2-ME (Sigma,
St Louis, MO.), 2 mM L-glutamine (J.H.R. Bioscience,
Lenexa, KS.) and penicillin/Streptomycin (GIBCO BRL,
Life Technologies Inc., Grand Island, NY). Flat-bottom
24-well plates (Falcon; Becton Dickinson Labware,
Lincoln Park, NJ) containing 1 ml of 20mg/ml of hamster
anti-mouse CD3 antibody (clone 145-2C11) were
incubated overnight at 58C. The following day, the
solution was removed and wells were washed by adding
1 ml of cold PBS. The PBS was removed and the wash step
repeated twice. One milliliter of each cell suspension was
added to each well. The supernatant was harvested at 72 h.
Cytokine ELISA
Sandwich ELISAs were done to measure IL5, IL10 and
IFN-g as previously described (Abrams, 1995). Briefly,
ELISA plates were coated with the appropriate anti-
cytokine antibodies and incubated at 48C overnight. After
incubation, plates were blocked for 30 min at room
temperature by adding 150ml of 20 % FCS in PBS
containing 0.04% TWEEN 20 (Sigma, St Louis MO.)
(FCS-PBST) to each well. Samples were diluted in 5%
FCS-RPMI and added to each well at a volume of 50ml
per well. Plates were incubated overnight at 48C then
washed and the second-step antibody that was diluted in
FCS-PBST was added at 50ml per well. Plates were
incubated for 1 h then washed and the enzyme conjugate
that was diluted in FCS-PBST was added to each well.
Plates remained at room temperature for 1 h after which
they were washed and 100ml per well of substrate
containing 1 mg/ml 2,20-azinobis(3-ethylbenzthiazoline-
sulfonic acid) (Sigma) and 0.003% H2O2 in 0.1 M
Na2HPO4 and 0.05 M citric acid was added. After the
substrate was developed, the reaction was stopped by
applying 0.05 ml of 0.2 M citric acid solution to each well.
The plates were read on an ELISA reader (Molecular
Devices Corporation, Menlo Park, CA).
Analysis of IL4
IL-4 from cultured supernatant was detected by a
bioassay using the IL4 dependent CT.4S cell line
(kindly donated by Dr William Paul, NIH) as previously
described (Seymour et al., 1997). Briefly, CT.4S cells
were resuspended in culture medium at a concentration of
1 £ 105=ml of medium. Standard and supernatants to be
tested were titered onto 96-well flat bottom plates at
50ml/well. The range of the standard was 100 to
0.78 pg/ml. The culture medium containing the CT.4S
cells was added to the wells at a volume of 50ml/well.
Plates were incubated for 72 h at 378C in a humidified
atmosphere containing 5% CO2. At the end of the
incubation period, 10ml of 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (Sigma) was added to
each well followed by 150ml of 0.04N HCL in isopro-
panol and the absorbance measured by an ELISA reader.
Passive Cutaneous Anaphylaxis (PCA)
Pooled serum samples from each group were serially diluted
in sterile PBS solution. Two white rats (250–300 gm) were
anesthesized with ether and their backs were shaved.
Intradermal injections were made (0.1 ml) of each dilution.
Negative control consisted on PBS. Separate aliquots of
serum were heat inactivated at 568C for 30 min, as a control
for non-IgE cytophilic antibodies (Braga and Mota, 1976).
Twenty four hours after sensitization rats were injected IV
with 5 mg OVA and 5 mg Evan’s blue dye in PBSS. After
20 min blue circles on the skin were observed and measured.
Statistics
Levels of antibodies, eosinophils and cytokines were
calculated as mean and standard error of the mean. The
two-tailed p values were calculated according to the
Mann-Whitney Test. A value of p , 0:05 was considered
significant. These statistical procedures permitted com-
parison between PBS control groups and the correspond-
ing various doses of Af antigen groups as well as between
air and ETS groups. Significance was considered at a
p-value of ,0.05. The airway responsiveness data was
expressed as the log of the EC200RL and analyzed using
analysis of variance with Scheffe’s joint estimation was
used for post hoc analysis (Statview, Abacus Concepts,
Inc.). A value of p , 0:05 was considered significant.
RESULTS
Increase in Airway Responsiveness in Af Sensitized
and PBS Control Mice Exposed to ETS
To determine if ETS without exposure to Af has an effect on
airway responsiveness, we compared EC200RL in
the PBS þ ETS group to the PBS þ AIR group.
Significant reduction in EC200RL was observed in the
PBS þ ETS group when compared to the PBS þ AIR
group (8:368 ^ 1:457 mg=ml vs. 24:332 ^ 5:735 mg=ml;
p , 0:05) (Fig. 2). Mice that had either 50 or 200mg of
Af per exposure had depressed lung function. Because of
their fragile state, a large number of the mice in these
groups were lost during the process of performing airway
responsiveness measurements. As a result of the bias that
the loss of the most severely affected mice in these groups
had on our analysis, data from the 200 ug Af groups was not
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included in the final analysis; data reported is from only the
mice that had 25mg Af per exposure. Analysis of the 25mg
Af þ AIR and Af þ ETS groups showed significant
differences in EC200RL between these groups
(1:208 ^ 0:301 mg=ml vs. 0:394 ^ 0:105 mg=ml; respect-
ively p , 0:05).
ETS Increases Blood Eosinophilia in Af Sensitized and
PBS Control Mice
Previous studies have shown that i.n. administration of Af
antigen results in increased numbers of eosinophils in
the blood for 5–7 days after sensitization followed by
a decline to baseline in about 2 weeks (Kurup et al.,
1994a). In the present study there was an increase in blood
eosinophils of all mice exposed to the 200 ug Af antigen
and also the 100 ug antigen dose (Fig. 3). At peak
response, 3 and 5 days (Fig. 3) after the final i.n. antigen
exposure (day 27 and 29, respectively), eosinophils were
significantly higher in the Af þ ETS group when
compared to the Af þ AIR group. By day 20 after the
final i.n. sensitization, eosinophils had declined in all Af
exposed groups but remained elevated above the PBS þ
AIR group. In another experiment, we observed that at this
timepoint, eosinophils in the PBS þ ETS group were
significantly elevated to 59:2 ^ 8:6 £ 104 compared to
28:0 ^ 3:8 £ 104 in the PBS þ AIR group ( p ¼ 0:0089;
n ¼ 10). Significant enhancement of eosinophil numbers
FIGURE 2 The effect of Af and ETS on airway responsiveness to acetylcholine aerosol in BALB/c mice. Animals were given 25mg Af per exposure or
PBS as described in Fig. 1 and airway responsiveness was measured on day 4 after the final i.n. sensitization. Airway responsiveness is expressed as the
log of the effective concentration of acetlycholine that doubles pulmonary flow resistance (Log (EC200RL)). *The mean EC200RL for each group was
significantly different ð p , 0:05Þ from each other group.
FIGURE 3 Eosinophil levels in the blood of BALB/c mice after exposure to ETS or ambient air. Experimental protocol was as described in Fig. 1.
Blood samples were collected in heparinized tubes and diluted in Descombe’s fluid Colley, 1972 for eosinophil determination. BALB/c mice were
sensitized i.n. with either 200mg Af per challenge or 100mg Af per challenge. * Indicates p , 0:05; versus all other groups ðn ¼ 10Þ: †Indicates
p ¼ 0:0177 versus Af þ ETS group ðn ¼ 23Þ:
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in the PBS þ ETS group was generally seen after 6 weeks
of ETS exposure. Peripheral eosinophilia was not seen
with the 25 ug dose.
Demonstration of Eosinophil Infiltration in Lungs of
Mice Exposed to Af
In lung sections from both Af þ AIR and Af þ ETS
exposed mice, areas of perivascular accumulation of
inflammatory cells contained numerous eosinophils as
well as some lymphocytes (Fig. 4). The eosinophilic cell
infiltrate appeared to be similar in both AIR and ETS
exposed groups, but was not present in lung sections that
were not sensitized with Af.
Aspergillus Specific IgE Measured by PCA
Pooled serum from mice receiving the 100 ug dose of Af
antigen in the ETS environment showed PCA titers greater
than 16. Similarly mice receiving Af antigen in filtered air
had PCA titers greater than 16. In contrast mice exposed
only to PBS in air or ETS showed negative PCA tests.
Heat inactivated samples were also negative.
Cytokine Production by Lung Cells Stimulated with
Anti-CD3
Homogenized lungs from all groups were stimulated
in vitro with plate-bound anti-CD3 on day 4 after the last
i.n. challenge and cytokine profiles were evaluated. The
PBS þ AIR group made detectable levels of IL5, IL10
and IFN-g but not IL4 (Table I). IL4, IL5 and IL10 were
significantly ( p , 0:005 for IL5 and IL10) elevated in
both Af sensitized groups when compared to the PBS
control groups, while IFN-g was not detectable. This
pattern is demonstrative of a polarized Th2 response.
However, there were no significant differences in the
cytokine responses from the homogenized lung of
Af þ ETS group when compared to the Af þ AIR group.
DISCUSSION
The experiments described herein focused on the effect of
ETS on BALB/c mice sensitized by the intranasal route to
Af antigen. The immunomodulatory effect of tobacco
smoke and its components have been well documented
(Thomas et al., 1975; Ronchetti et al., 1990; Stone, 1992;
Sopori et al., 1993; Abrams, 1995; Geng et al., 1995;
El-Nawawy et al., 1996; Geng et al., 1996; Oryszczyn
et al., 2000; Gilliland et al., 2001). In our previous studies
we showed that prolonged exposure of OVA sensitized
mice to ETS resulted in enhanced levels of serum IgE,
IgG1, and blood eosinophils (Seymour et al., 1997).
Experimental ABPA has been well described in the mouse
model (Grunig et al., 1998a). Mice exposed by the
i.n. route to Af antigen characteristically develop high total
IgE, IgG1, peripheral and pulmonary eosinophilia and
TABLE I Cytokines produced after anti-CD3 stimulation of homogenized lung cells from Af sensitised and control mice
Sensitization (i.n.) Exposure IL4 ng/ml IL5 ng/ml IL10 u/ml IFN-g ng/ml
PBS AIR ,0.08 0.99 ^ 0.31 6.3 ^ 1.0 3.45 ^ 0.96
PBS ETS ,0.08 0.50 ^ 0.05 ,2.5 3.65 ^ 0.89
100mg Af/challenge AIR 0.25 ^ 0.06 2.70 ^ 0.80 13.6 ^ 6.4 ,0.313
100mg Af/challenge ETS 0.44 ^ 0.16 2.00 ^ 0.40 11.0 ^ 3.7 ,0.313
200mg Af/challenge AIR 0.35 ^ 0.05 3.24 ^ 0.36 21.6 ^ 2.5 ,0.313
200mg Af/challenge ETS 0.57 ^ 0.11 3.66 ^ 0.41 19.1 ^ 1.8 ,0.313
In vitro stimulation was performed on day 4 after final i.n. sensitization as described in the methods section. Results show the mean and SEM of 12 mice per group.
FIGURE 4 H and E stained paraffin section from the Af (high dose)
þAIR group. Area of perivascular inflammation found in both air and
ETS groups (panel A, bar ¼ 50mm). The perivascular influx contains
eosinophils (arrow), (panel B, bar ¼ 10mm).
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bronchial hyperresponsiveness (Wang et al., 1994).
Herein, we reported that Af sensitized mice developed
high peripheral and pulmonary eosinophilia, bronchial
hyperresponsiveness and allergen-specific IgE as
expected. However, when ETS exposed Af sensitized
mice were compared to filtered air housed Af sensitized
mice, our data showed statistically significant ETS
exacerbation of airway hyper-responsiveness and periphe-
ral eosinophilia.
A significant elevation of eosinophils was observed in
the blood of PBS þ ETS mice after 6 weeks of ETS
exposure demonstrating that prolonged exposure to ETS
alone can enhance eosinophilia in mice. Similarly, studies
in humans have also shown significant blood eosinophilia,
independent of serum IgE, as a result of inhalation of
second-hand smoke (Ronchetti et al., 1990). Tobacco
smoke, a complex mixture of over 4000 different
chemicals (Stedman, 1968) contains substances that can
induce inflammation and respiratory irritation (Shephard,
1992; Witschi et al., 1997). Indeed, these substances have
been shown to activate histamine from mast cells in
smokers (reviewed in Holt, 1987). The fragments from the
mycelia of Af, a component of the Af extract used in this
study, can induce degranulation of sensitized mast cells to
secrete chemotactic factors as well as Th2 type cytokines
(Kauffman et al., 1995). Moreover, mast cell degranula-
tion by IgE antibody results in both bronchoconstriction
and eosinophil chemotaxis (Wardlaw et al., 1988). We
examined pooled sera from the Af þ ETS and pooled sera
from the Af þ AIR groups and both were positive for Af-
specific IgE by heterologous passive cutaneous anaphyl-
axis on rat skin. It is therefore, possible that mast cells
degranulation was actively involved in the recruitment of
eosinophils in the blood of Af þ ETS group.
IL5, known to increase eosinophilic leukocytes (Galli
et al., 1991; Kurup et al., 1994b; Hogaboam et al., 1999) was
detected from anti-CD3 stimulated cells. However,
additional sources of IL5 from smoke stimulated mast
cells were not measured in vitro, which may explain the lack
of enhancement of IL5, after invitro stimulation of lung cells
from the Af þ ETS group when compared to the Af þ AIR
group. There are other probable reasons for the higher levels
of eosinophils in ETS exposed mice such as the production
of the chemokines C10 and eotaxin. These mediators of
eosinophilia were not measured in this study but were
previously demonstrated in a murine model of ABPA
(Hogaboam et al., 1999). Proust et al. showed that intranasal
anti-IL-5 treated OVA allergic mice had decreased BAL
eosinophilia, but unchanged bronchial hyperresponsiveness
and lung eosinophil sequestration (Shen et al., 2003). This is
in agreement with the lack of correlation of T cell-derived
IL-5 with lung and peripheral eosinophilia and increased
bronchial hyperresponsiveness seen in the present study.
Exposure of naı¨ve mice to ETS alone produced an
increase in airway responsiveness to acetylcholine
confirming similar studies in humans showing that
exposure to ETS alone causes nonspecific increases in
airway reactivity to methacholine (Menon et al., 1992).
However, airway hyperresponsiveness was greater in the
Af exposed groups. When we exposed naive mice to Af in
the presence or absence of ETS, we observed the
characteristic Th2 cytokine response and no IFN-g after
in vitro restimulation of homogenized lung with anti-CD3.
Though the cytokine response was similar in both Af
sensitized groups, there was a significant difference in
airway hyperresponsiveness between them. Thus some
synergism between Af and ETS in the establishment of
airway hyperresponsiveness is suggested. In addition,
these findings suggest that Af-induced increase in airway
responsiveness represented an extremely sensitive end-
point that does not necessarily correlate with the cytokines
observed from our in vitro stimulation of lung cells. Thus
we believe cytokines not tested may have been responsible
for the synergistic effect of the Af and ETS with respect to
bronchial hyperresponsiveness. For example, the cyto-
kine, IL-13 that was not examined in this study, instead of
IL-4, was shown by others to be the most important
cytokine in inducing bronchial hyperresponsiveness
(Grunig et al., 1998b). Other investigators have also
demonstrated the importance of eosinophil in an allergic
asthma model using IL-4 knock out mice in which neither
IgE nor IL-4 were present, but airway hyperreactivity was
demonstrated (Hogan et al., 1997).
These data suggest that the profound airway hyper-
responsiveness and eosinophilia observed in Af allergic
mice is exacerbated by the ETS environment. The
immunomodulatory effects of ETS and the relationship
between allergen dosage and this effect pose interesting
problems for future study.
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